カテゴリ： MarketLine, イギリス, 企業調査

Legal & General Group Plc：企業のM&A・事業提携・投資動向

◆英語タイトル：Legal & General Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード：DATA904C1309
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：92
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD700 ⇒換算￥103,600見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD1,050 ⇒換算￥155,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Legal & General Group Plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Legal & General Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Legal & General Group Plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Legal & General Group Plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Legal & General Group Plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Legal & General Group Plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Legal & General Group Plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Legal & General Group Plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Legal & General Group Plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 28
Corporate Venturing – Overview 28
Corporate Venturing – Deal reports 29
PARTNERSHIP 31
Partnership – Overview 31
Partnership – Deal reports 32
CAPITAL RAISING 45
Capital Raising – Overview 45
Capital Raising – Deal reports 46
DIVESTMENTS 47
Divestments – Overview 47
Divestments – Deal reports 48
APPENDIX 82
Contact Us 82
About MarketLine Financial Deals Database 82
Deal Definition and Methodology 84
About MarketLine 91

List of Tables
Table 1: Legal & General Group Plc M&A volume and value trend (2014-YTD2018)
Table 2: Legal & General Group Plc M&A activity by geography (2014-YTD2018)
Table 3: Legal & General Group Plc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Legal & General Group Plc corporate venturing by geography (2014-YTD2018)
Table 5: Legal & General Group Plc partnership volume and value trend (2014-YTD2018)
Table 6: Legal & General Group Plc partnership trend by key deal type (2014-YTD2018)
Table 7: Legal & General Group Plc capital raising volume and value trend (2014-YTD2018)
Table 8: Legal & General Group Plc capital raising by deal type (2014-YTD2018)
Table 9: Legal & General Group Plc divestments volume and value trend (2014-YTD2018)
Table 10: Legal & General Group Plc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Legal & General Group Plc M&A volume and value trend (2014-YTD2018)
Figure 2: Legal & General Group Plc M&A activity by geography (2014-YTD2018)
Figure 3: Legal & General Group Plc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Legal & General Group Plc corporate venturing by geography (2014-YTD2018)
Figure 5: Legal & General Group Plc partnership volume and value trend (2014-YTD2018)
Figure 6: Legal & General Group Plc partnership trend by key deal type (2014-YTD2018)
Figure 7: Legal & General Group Plc capital raising volume and value trend (2014-YTD2018)
Figure 8: Legal & General Group Plc capital raising by deal type (2014-YTD2018)
Figure 9: Legal & General Group Plc divestments volume and value trend (2014-YTD2018)
Figure 10: Legal & General Group Plc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Legal & General Group Plc：企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • XERIS Pharmaceuticals Inc (XERS)：製薬・医療：M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Oaks Hotels & Resorts Limited
    Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report Summary Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Britvic Plc：企業の戦略・SWOT・財務情報
    Britvic Plc - Strategy, SWOT and Corporate Finance Report Summary Britvic Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • GGP Inc：企業の戦略・SWOT・財務情報
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • The National Petrochemical Co：企業の戦略的SWOT分析
    The National Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Alliqua BioMedical Inc (ALQA)-医療機器分野：企業M&A・提携分析
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial …
  • Hindustan Organic Chemicals Limited (HOCL)：企業の財務・戦略的SWOT分析
    Hindustan Organic Chemicals Limited (HOCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Shionogi & Co., Ltd.：企業の戦略・SWOT・財務情報
    Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Blue Cross and Blue Shield Association：企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Adamis Pharmaceuticals Corp (ADMP)-医療機器分野：企業M&A・提携分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe …
  • F. Hoffmann-La Roche Ltd：企業のM&A・事業提携・投資動向
    F. Hoffmann-La Roche Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's F. Hoffmann-La Roche Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Bumi Armada Bhd (ARMADA)：石油・ガス：M&Aディール及び事業提携情報
    Summary Bumi Armada Bhd (Bumi Armada) is an integrated offshore solutions provider. The company owns and operates Floating Production Storage & Offloading (FPSO), Offshore Support Vessels (OSV), pipelaying barges, and subsea vessels. Its FPSO portfolio includes Armada TGT 1, Armada Sterling, Armada …
  • ASOS Plc：企業の戦略・SWOT・財務情報
    ASOS Plc - Strategy, SWOT and Corporate Finance Report Summary ASOS Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Development Bank of Southern Africa：企業の戦略的SWOT分析
    Development Bank of Southern Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • British Columbia Cancer Agency：製薬・医療：M&Aディール及び事業提携情報
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as diagnostic and therapy planning, radiation therapy, patient assessment …
  • Xintela AB (XINT)：企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • NACHI-FUJIKOSHI CORP.：企業の戦略・SWOT・財務情報
    NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report Summary NACHI-FUJIKOSHI CORP. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Adaptimmune Therapeutics Plc (ADAP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Adaptimmune Therapeutics Plc (Adaptimmune), formerly Adaptimmune Therapeutics Limited, is a clinical stage biopharmaceutical company that develops innovative T-cell therapy products for the treatment of cancer. It harnesses the proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) …
  • MegaChips Corporation (6875)：企業の財務・戦略的SWOT分析
    MegaChips Corporation (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Inotek Pharmaceuticals Corp (RCKT)：製薬・医療：M&Aディール及び事業提携情報
    Summary Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The company’s trabodenoson is a selective adenosine mimetic that stimulates a speci …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆